跳至主要内容
临床试验/EUCTR2019-001131-31-DK
EUCTR2019-001131-31-DK进行中(未招募)1 期

Efficacy and safety of 72-hour infusion of Prostacyclin (1 ng/kg/min) in patients with septic shock induced endotheliopathy – a multicentre randomized, placebo-controlled, blinded, investigator-initiated trial”

Section for transfusion Medicines, Capital Region Blood Bank, Copenhagen University Hospital0 个研究点目标入组 380 人开始时间: 2019年3月15日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
380

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Adult intensive care patients (age = 18 years)
  • 2. Septic shock, defined as (i) suspected or documented infection, (ii) persisting hypotension requiring vasopressors to maintain MAP =65 mm Hg AND a lactate level >2 mmol/L despite fluid therapy
  • 3. sTM > 10 ng/mL
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 180
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 200

排除标准

  • 1. Withdrawal from active therapy
  • 2. Pregnancy (non-pregnancy confirmed by patient having a negative urine- or plasma hCG or being postmenopausal defined as females at 60 years old and beyond or at the investigators discretion)
  • 3. Known hypersensitivity to iloprost or to any of the other ingredients.
  • 4. Life-threatening bleeding as defined by the treating physician
  • 5. Known severe heart failure (NYHA class IV)
  • 6. Suspected acute coronary syndrome
  • 7. Previously included in this trial
  • 8. Screening > 12 hours after diagnosis of septic shock
  • 9. Informed consent cannot be obtained
  • 10. Included in clinical trials with prostacyclin within the last 90 days

研究者

发起方
Section for transfusion Medicines, Capital Region Blood Bank, Copenhagen University Hospital

相似试验

进行中(未招募)
1 期
Efficacy and safety of 72-hour infusion of Prostacyclin (1 ng/kg/min) in trauma patients with haemorrhagic shock suffering from organ failure caused by endothelial breakdowShock-induced endotheliopathy in trauma patientsMedDRA version: 20.1Level: LLTClassification code 10044528Term: Traumatic injurySystem Organ Class: 100000004863
EUCTR2019-000936-24-NOSection for Transfusion Medicine, Capital Region Blood Bank, Copenhagen University Hospital220
进行中(未招募)
1 期
Efficacy and safety of 72-hour infusion of Prostacyclin (1 ng/kg/min) in mechanically ventilated patients with infectious respiratory failureInfectious pulmonary endotheliopathyMedDRA version: 20.0Level: LLTClassification code 10038696Term: Respiratory failure (excl neonatal)System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2022-004079-17-DKRigshospitalet450
招募中
1 期
COMBAT-ARFInfectious pulmonary endotheliopathyMedDRA version: 20.0Level: LLTClassification code: 10038696Term: Respiratory failure (excl neonatal) Class: 10038738
CTIS2024-512641-16-00Rigshospitalet450
进行中(未招募)
1 期
Efficacy and safety of 72-hour infusion of Prostacyclin (1 ng/kg/min) in trauma patients with haemorrhagic shock suffering from organ failure caused by endothelial breakdow
EUCTR2019-000936-24-DKSection for Transfusion Medicine, Capital Region Blood Bank, Copenhagen University Hospital220
进行中(未招募)
1 期
Efficacy and safety of 72-hour infusion of Prostacyclin (1 ng/kg/min) in patients with COVID-19 induced respiratory failure – a multicentre randomized, placebo-controlled, blinded, investigator-initiated trialCOVID-19 induced respiratory failureMedDRA version: 20.0Level: LLTClassification code 10038696Term: Respiratory failure (excl neonatal)System Organ Class: 100000004855MedDRA version: 20.0Level: LLTClassification code 10040050Term: Sepsis NOSSystem Organ Class: 100000004862
EUCTR2020-001296-33-DKSection for Transfusion Medicine, Capital Region Blood bank, Copenhagen University Hospital80